Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-04-19
2011-04-19
Huff, Sheela J (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387700, C530S387900, C530S389700, C530S391100, C530S391300, C530S391700
Reexamination Certificate
active
07928202
ABSTRACT:
The invention relates to methods for treating a subject by manipulating ABCB5 on a cell as well as related products. The methods include methods of treating cancer using ABCB5 binding molecules such as antibodies and fragments thereof.
REFERENCES:
patent: 4382441 (1983-05-01), Svedman
patent: 4587101 (1986-05-01), Marsoner et al.
patent: 4817594 (1989-04-01), Juhasz
patent: 5399483 (1995-03-01), Shibano et al.
patent: 5565354 (1996-10-01), Ostberg
patent: 5567610 (1996-10-01), Borrebaeck et al.
patent: 5569825 (1996-10-01), Lonberg
patent: 5571893 (1996-11-01), Baker et al.
patent: 5759570 (1998-06-01), Arnold
patent: 5833641 (1998-11-01), Curtis et al.
patent: 5904659 (1999-05-01), Duarte et al.
patent: 6071267 (2000-06-01), Zamierowski
patent: 6846883 (2002-03-01), Frank et al.
patent: 6420622 (2002-07-01), Johnston et al.
patent: 6459109 (2002-10-01), Henley et al.
patent: 6479072 (2002-11-01), Margan et al.
patent: 6632656 (2003-10-01), Andersson et al.
patent: 6685681 (2004-02-01), Lockwood et al.
patent: 6755807 (2004-06-01), Risk, Jr. et al.
patent: 6767194 (2004-07-01), Jeon et al.
patent: 6855135 (2005-02-01), Lockwood et al.
patent: 6867342 (2005-03-01), Johnston et al.
patent: 6899873 (2005-05-01), Ma et al.
patent: 7202346 (2007-04-01), Payne et al.
patent: 2001/0007658 (2001-07-01), Usala et al.
patent: 2002/0068913 (2002-06-01), Fleischmann
patent: 2002/0115967 (2002-08-01), Svedman
patent: 2002/0127736 (2002-09-01), Chou et al.
patent: 2002/0150720 (2002-10-01), Howard et al.
patent: 2004/0243073 (2004-12-01), Lockwood et al.
patent: 2005/0004534 (2005-06-01), Lockwood et al.
patent: 2005/0249728 (2005-11-01), Singh et al.
patent: 2005/0251083 (2005-11-01), Carr-Brendel et al.
patent: 2006/0177455 (2006-08-01), Hoffee et al.
patent: 0 174 810 (1986-03-01), None
patent: 0 267 781 (1988-05-01), None
patent: 98361 (2001-12-01), None
patent: WO 2005/046762 (2005-05-01), None
patent: 068503 (2005-07-01), None
Frank et al. Cancer Research 2005; 65 (10): 4320-4333).
Paul, Fundamental Immunology, 3rd Edition, 1993, pp. 292-295.
Rudikoff et al(Proc. Natl. Acad. Sci. USA 1982 vol. 79: p. 1979).
Pascalis et al (The Journal of Immunology (2002) 169, 3076-3084).
Casset et al. (2003) BBRC 307, 198-205.
Brown et al (J. Immunol. May 1996; 156(9):3285-3291.
Vajdos et al (J. Mol. Biol. Jul. 5, 2002;320(2); 415-428).
Bork, Powers and Pitfalls in Sequence Analysis: The 70% Hurdle. Genome Res. 10:398-400 (2000).
Bork et al., Go Hunting in Sequence Databases But Watch Out for Traps. Trends in Genetics 12:425-427 (1996).
Bowie et al., Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions. Science 247:1306-1311 (1990).
Brenner, Errors in Genome Annotation. Trends in Genetics 15:132-133 (1999).
Burgess et al., Possible Dissociation of the Heparin-Binding and Mitogenic Activities of Heparin-Binding (Acidic Fibroblast) Growth Factor-1 from Its Receptor-Binding Activities by Site-Directed Mutagenesis of a Single Lysine Residue. J. Cell Biol. 111:2129-2138 (1990).
Chung et al., Plastic microchip flow cytometer based on 2- and 3-dimensional hydrodynamic flow focusing. Microsystem Technologies 9 Springer-Verlag 525-533 2003.
Dermer, Another Anniversary of the War on Cancer. Bio/Technology 12:320 (1994).
Doerks et al., Protein Annotation: Detective Work for Function Prediction. Trends in Genetics 14:248-250 (1998).
Frank et al., Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter. J Biol. Chem. Nov 21, 2003; 278(47):47156-65. Epub Sep 7, 2003.
Frank et al., ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res. May 15, 2005;65(10):4320-33.
Frank M. H. et al., Immunomodulatory functions of mesenchymal stem cells., The Lancet, Lancet Limited London, GB, 363(9419): May 2004 p. 1411-1412.
Frank M. H. et al., Specific MDR1 P-Glycoprotein Blockade Inhibits Human Alloimmune T Cell Activation In Vitro. J. of Immunol. 2001, 166: p. 2451-2459.
Frank N. et al., ABCB5 P-glycoprotein is a molecular marker of the Hoechst 33342 side population phenotype among human fetal skeletal muscle cells. FASEB Journal 18(4-5) 2004 p. 144.9.
Freshney, Culture of Animal Cells, A Manual of Basic Technique. Alan R. Liss, Inc., 1983, New York, p. 3-4.
Georges et al., Detection of P-Glycoprotein Isoforms by Gene-Specific Monoclonal Antibodies, Proc. Natl. Acad. Sci. USA 87:152-156 (1990).
International Search Report—PCT/US01/18032, dated May 13, 2002.
International Search Report—PCT/US2007/013022, dated Aug. 11, 2007.
Jakobovits et al., Analysis of homozygous mutant chimeric mice: Deletion of the immunoglobulin heavy-chain joining region blocks B-cell development and antibody production. Proc. Natl. Acad. Sci. USA vol. 90 Mar. 1993 p. 2551-2555.
Jorgensen C. et al., Engineering mesenchymal stem cells for immunotherapy. Gene Therapy, MacMillan Press Ltd. Basingstoke, GB, 10(10): May 2003 pp. 928-931.
Kalicki et al., The Sequence ofH. sapiensBAC Clone CTA-367017, EMBL/GenBank/DDBJ Databases (Abstract) (1997).
Knutsen et al., Cytogenetic and Molecular Characterization of Random Chromosomal Rearrangements Activating the Drug Resistance Gene, MDRI/P-Glycoprotein, in Drug-Selected Cell Lines and Patients with Drug Refractory ALL. Genes, Chromosomes & Cancer 23:44-54 (1998).
Kunkel, Rapid and efficient site-specific mutagenesis without phenotypic selection, Proc. Natl. Acad. Sci. USA vol. 82 Jan. 1985 p. 488-492.
Lazar et al., Transforming Growth Factor α: Mutation of Aspartic Acid 47 and Leucine 48 Results in Different Biological Activities. Molecular and Cellular Biology 8:1247-1251 (1988).
Mickley et al., Gene Rearrangement: A Novel Mechanism for MDR-1 Gene Activation. J. Clin. Invest. 99:1947-1957 (1997).
Pendse et al., P-Glycoprotein Functions as a Differentiation Switch in Antigen Presenting Cell Maturation. Am J Transplant Dec. 2008; 6(12):2884-93.
Schatton et al., Identification of cells initiating human melanomas. Nature. Jan. 17, 2008; 451(7176):345-9.
Schatton et al., The Chemoresistance Mediator ABCB5 Identifies Melanoma Stem Cells. 14thSPORE Investigator's Workshop 2006, Abstract 150 p. 92.
Schoenlein et al., Double Minute Chromosomes Carrying the Human Multidrug Resistance 1 and 2 Genes are Generated from the Dimerization of Submicroscopic Circular DNAs in Colchicine-Selected KB Carcinoma Cells. Molec. Biol. of the Cell 3:507-520 (1992).
Scott et al., The Pendred Syndrome Gene Codes a Chloride-Iodide Transport Protein. Nature Genomics 21:440-443 (1999).
Shi C-M et al., Transplantation of dermal multipotent cells promotes the hematopoietic recovery in recovery in sublethally irradiated rats. J. Radiation Res. 45(1): Mar. 2003 p. 19-24.
Skolnick et al., From Genes to Protein Structure and Function: Novel Applications of Computational Approaches in the Genomic Era. Trends in Biotech. 18:34-39 (2000).
Smith et al., The Challenges of Genome Sequence Annotation or ‘The Devil is in the Details’ Nature Biotechnology 15:1222-1223 (1997).
Sequence Comparison cited in parent U.S. Appl. No. 09/873,409 (Apr. 2, 2003 Office Action).
Sequence Comparison cited in parent U.S. Appl. No. 09/873,409 (Dec. 31, 2003 Office Action).
Unger et al. Monolithic Microfabricated Valves and Pumps by Multilayer Soft Lithography. Science Apr. 7 288:113-113 2000.
Whitesides & Stroock, Flexible Method for Microfluidics Devices for handling nanoliter quantities of fluids are creating new fabrication challenges and finding new applications in biology, chemistry and materials science. Physics Today Online, Jun. 2001 p. 1-8.
Young H. E. et al., Adult-derived stem cells and their potential for use in tissue repair and molecular medicine. J. Cellular and Molecular Med. 9(3): Jul. 2005 p. 753-769.
Frank Markus H.
Frank Natasha Y.
Sayegh Mohamed H.
Huff Sheela J
The Brigham and Women's Hospital, Inc.
Wolf Greenfield & Sacks P.C.
LandOfFree
Targeting ABCB5 for cancer therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeting ABCB5 for cancer therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeting ABCB5 for cancer therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2673612